Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024

Rhea-AI Summary

Rockwell Medical, Inc. (Nasdaq: RMTI), a healthcare company specializing in hemodialysis products, has announced the release of its third quarter 2024 financial and operational results on Monday, November 11, 2024. The company will issue a press release at 6:00am ET, followed by a live conference call and webcast at 8:00am ET.

The conference call details are as follows:

• Date: Monday, November 11, 2024
• Time: 8:00am ET
• Live Number: (888) 660-6347 (US) / 1 (929) 201-6594 (International)
• Conference Call ID: 4944610
• Webcast and Replay: www.RockwellMed.com/Results

The call will include a discussion of the third quarter 2024 financial and operational results, followed by a Q&A session.

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the third quarter ended September 30, 2024 on Monday, November 11, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

CONFERENCE CALL AND WEBCAST DETAILS

Date: Monday, November 11, 2024

Time: 8:00am ET

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Conference Call ID: 4944610

Webcast and Replay: www.RockwellMed.com/Results

Format: Discussion of third quarter 2024 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work^® in 2023 and 2024 and named Fortune Best Workplaces in Manufacturing & Production^TM in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions^TM. For more information, visit www.RockwellMed.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241014194306/en/

Heather R. Hunter

SVP, Chief Corporate Affairs Officer

(248) 432-1362

IR@RockwellMed.com

Source: Rockwell Medical

FAQ

When will Rockwell Medical (RMTI) release its Q3 2024 earnings?

Rockwell Medical (RMTI) will release its third quarter 2024 financial and operational results on Monday, November 11, 2024.

What time is Rockwell Medical's (RMTI) Q3 2024 earnings call?

Rockwell Medical's (RMTI) Q3 2024 earnings conference call is scheduled for 8:00am ET on Monday, November 11, 2024.

How can I access Rockwell Medical's (RMTI) Q3 2024 earnings webcast?

You can access Rockwell Medical's (RMTI) Q3 2024 earnings webcast and replay at www.RockwellMed.com/Results.

What is the conference call ID for Rockwell Medical's (RMTI) Q3 2024 earnings call?

The conference call ID for Rockwell Medical's (RMTI) Q3 2024 earnings call is 4944610.